Wilson's disease: Molecular basis, clinical manifestations, and rational treatment

被引:0
|
作者
Beuers, U
Gasser, T
机构
[1] Univ Munich, Klinikum Grosshadern, Med Klin 2, D-81377 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Neurol Klin, D-81377 Munich, Germany
来源
MEDIZINISCHE WELT | 1998年 / 49卷 / 03期
关键词
Wilson's disease; pathogenesis; diagnosis; treatment;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Wilson's disease is a hereditary disorder of copper metabolism which mainly affects the liver and the central nervous system, but also other organs. It is caused by an impairment of biliary copper excretion and subsequent accumulation of copper in the organism. Mutations in one single gene on chromosome 13 have been identified as the cause of impaired copper excretion. The product of the "Wiison's disease gene" is a copper transporting membrane protein. Patients develop symptoms of the disease mainly between the ages of 5 and 30 years. They may present with fulminant hepatic failure and hemolysis or with signs or symptoms of chronic hepatopathy or movement disorders. The diagnosis is made by clinical, biochemical and histological examinations. The prognosis is good when the diagnosis is made at time and when adequate long-term medical treatment is administered. Wilson's disease, however, is fatal when untreated. liver transplantation is indicated in patients with fulminant hepatic failure or end stage chronic liver disease.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 50 条
  • [41] Mowat-Wilson disease with unusual clinical manifestations.
    Tegay, DH
    Weiss-Burns, J
    Galvin-Parton, P
    GENETICS IN MEDICINE, 2004, 6 (04) : 311 - 311
  • [42] Disappearance of the clinical and imaging manifestations in Wilson's disease after controlled therapy with tetrathiomolybdate and zinc
    Posada, I.
    Garfia, C.
    Ostos, F.
    Ramos, A.
    MOVEMENT DISORDERS, 2017, 32
  • [43] WILSON'S DISEASE: A CHALLENGING DIAGNOSIS. CLINICAL MANIFESTATIONS AND DIAGNOSTIC PROCEDURES IN 12 PATIENTS
    Hancu, Anca
    Mihai, Maria Cristina
    Axelerad, Any Docu
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2011, 115 (01): : 58 - 63
  • [44] Molecular diagnosis of Wilson's disease
    Shimizu, N
    Nakazono, H
    Watanabe, A
    Yamaguci, Y
    Hemmi, H
    Aoki, T
    LANCET, 1997, 349 (9068): : 1811 - 1812
  • [45] Imaging and Clinical Worsening After Penicillamine Treatment in Wilson's Disease
    Teive, Helio A. G.
    de Carvalho, Arnolfo
    Munhoz, Renato P.
    Moro, Adriana
    Moscovich, Mariana
    Barbosa, Egberto Reis
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2015, 2 (04): : 447 - 448
  • [46] Clinical, biochemical and radiological profile of Wilson's disease and effect of treatment
    Kumar, N.
    Joshi, D.
    JOURNAL OF NEUROLOGY, 2012, 259 : S31 - S32
  • [47] Wilson's disease with neurological manifestations and normal cerebral MRI
    Tarta-Arsene, O.
    Dinu, C. E.
    Iliescu, C. M.
    Gandea, M.
    Magureanu, S. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 76 - 77
  • [48] Neurological manifestations in Wilson's disease:: Report of 119 cases
    Machado, Alexandre
    Chien, Hsin Fen
    Deguti, Marta Mitiko
    Cancado, Eduardo
    Azevedo, Raymundo Soares
    Scaff, Milberto
    Barbosa, Egberto Reis
    MOVEMENT DISORDERS, 2006, 21 (12) : 2192 - 2196
  • [49] Wilson's disease - Update of a systemic disorder with protean manifestations
    Cuthbert, JA
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1998, 27 (03) : 655 - +
  • [50] Treating the Neurologic Manifestations of Wilson's Disease With Liver Transplantation
    Marmol, Sarah
    Maeder-York, Paul Walker
    Hislop, Jennifer
    Shpiner, Danielle S.
    Margolesky, Jason
    NEUROHOSPITALIST, 2023, : 99 - 103